NDTVCenter·
Emcure Pharma Review: Jefferies, Kotak Maintain Buy; Raise Growth Estimates
Emcure Pharmaceuticals' Q2 performance and improving growth outlook have prompted Jefferies and Kotak to maintain their Buy ratings.
Read at NDTV →
Business · 1 sources covering this
Emcure Pharma Review: Jefferies, Kotak Maintain Buy; Raise Growth Estimates
Emcure Pharmaceuticals' Q2 performance and improving growth outlook have prompted Jefferies and Kotak to maintain their Buy ratings.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/a44ddf4abe11333cc6b448f8af38557d21bfec20" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Emcure Pharma Review: Jefferies, Kotak Maintain Buy; Raise Growth Estimates"></iframe>
